New study tests better pain relief for mastectomy patients
NCT ID NCT07394868
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of nerve blocks for pain after modified radical mastectomy. One block is placed under the chest muscle, the other above it, and a third combines both. The goal is to see which approach reduces opioid use and pain scores most effectively. Sixty women aged 18-80 will be enrolled and monitored for 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- serratus anterior plane block (nerve block with local anesthetic)
- What this could lead to
- If successful, this could show that combining two nerve block techniques provides better pain relief after mastectomy than using just one.
- What could go wrong
- This is a small, early-stage study with only 60 participants. The results may not apply to all patients, and the blocks carry rare risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who undergone mastectomy surgery
- Ages
-
18 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 18-80 years * Individuals with ASA scores I-II-III * Individuals with a Body Mass Index (BMI) between 18-40 Exclusion Criteria: * Individuals under 18 years of age and over 80 years of age * Individuals with an ASA score of IV or higher * Individuals with advanced comorbidities * Individuals with a history of bleeding diathesis * Patients with infection in the area to be blocked * Individuals with a BMI below 18 and above 40
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Etlik City Hospital
Ankara, Varlık Mahallesi, Halil Sezai Erkut Caddesi Yenimahalle, 06170, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Can a finger sensor reveal whether an epidural is working?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?